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Overview: West Nile virus (WNV) is a zoonotic
mosquito-borne virus with a broad host range 
that infects mainly birds and mosquitos, but also
mammals (including humans), reptiles, amphibians
and ticks. It is maintained in a bird–mosquito–bird
transmission cycle. The most important vectors are
bird-feeding mosquitos of the Culex genus;
maintenance and amplification mainly involve
passerine birds. WNV can cause disease in humans,
horses and several species of birds following
infection of the central nervous system.
Infection in cats: Cats can also be infected
through mosquito bites, and by eating infected
small mammals and probably also birds. Although
seroprevalence in cats can be high in endemic
areas, clinical disease and mortality are rarely
reported. If a cat is suspected of clinical signs due
to an acute WNV infection, symptomatic treatment
is indicated.
Introduction
West Nile virus (WNV) is a zoonotic mosquito-borne virus belonging
to the family Flaviviridae, genus Flavivirus, in the Japanese encephalitis
antigenic group. It is an enveloped virus containing a single molecule
of linear, positive-sense, single-stranded RNA. Several phylogenetic
lineages can be distinguished but most isolates can be assigned to 
lineages 1 and 2. WNV has a broad host range, comprising mainly
birds and mosquitos, but also mammals (including humans), reptiles,
amphibians and ticks. It can cause disease in humans, horses and 
several species of birds. The severity of disease depends on the
(neuro)virulence of the infecting virus strain. Disease is uncommon in
other wild and domesticated animals, and has been incidentally reported
in alpacas, sheep, reindeer, dogs and also cats.1
Epidemiology
WNV was first identified in 1937 from the blood of a febrile patient in
the West Nile district of Uganda. Since then, the virus has spread from
Africa via migratory birds to other parts of the world including Central
and Southern Europe, Asia and Australasia.1,2 In 1999, the virus was
introduced into North America, in the city of New York, causing
encephalomyelitis in horses, birds and humans. Since then, the virus
has spread across the USA and parts of Latin America and Canada.3
WNV is maintained in a bird–mosquito–bird transmission cycle. The
most important vectors are bird-feeding mosquitos of the Culex genus.
More than 300 species of birds have been reported to be infected with
WNV, but maintenance and amplification mainly involve passerine
birds.4 These birds develop viraemia levels that are sufficient to infect
mosquitos feeding upon them. Mortality differs between bird species.
High mortality is seen especially in corvids and robins. In other species
of wild birds, and also chickens and pigeons, infection remains sub-
clinical. In these latter species a low-magnitude viraemia develops
which is unlikely to be sufficient to again infect mosquitos. Humans
and other mammals also develop low levels of viraemia and are there-
fore considered dead-end hosts and not important as virus reservoirs.1
European Advisory Board on Cat Diseases
The European Advisory Board on Cat Diseases (ABCD) is
a body of experts in immunology, vaccinology and clinical
feline medicine that issues guidelines on prevention and
management of feline infectious diseases in Europe, for the
benefit of the health and welfare of cats. The guidelines are
based on current scientific knowledge of the diseases and
available vaccines concerned.
The latest version of the West Nile virus 
infection in cats guidelines is available at 
www.abcdcatsvets.org and www.abcd-vets.org
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Pathogenesis and clinical signs
Infection occurs mainly through inoculation
of virus by a mosquito bite. Initial target cells
are keratinocytes and skin-resident dendritic
cells (DCs).5 The latter migrate to draining
lymph nodes where initial replication occurs.
From there, the virus spreads to visceral
organs, including the spleen. The target cells
in the spleen and other visceral organs are
thought to be DCs, macrophages and 
neutrophils. Viral replication leads to
viraemia. The virus enters the central nervous
system (CNS), resulting in inflammation of
the medulla, brainstem and spinal cord.6
Similarly to other mammals and birds, cats
can be infected through mosquito bites, but also
orally by eating infected small mammals and
probably also birds, as evidenced by serological
studies and experimental infections.7 In a sero-
logical survey conducted in St Tammany
Parish, Louisiana, USA, 9% of cats were shown
to be seropositive, with stray cats having almost
three times the WNV seroprevalence as family
cats, although the difference was not signifi-
cant.8 Seropositive cats were also identified in
other areas of the USA and in China, with sero-
prevalence rates ranging from 10–15%.9,10
Although seroprevalence of WNV infection
in endemic areas can be high, clinical disease
and mortality are rarely reported. It seems
that most infections are subclinical in nature. 
In 33 cats from Germany with non-suppura-
tive meningoencephalitis of unknown origin,
positive immunostaining was detected for
WNV antigen in four cats. All four cats had
shown neurological signs. However, WNV
infection could not be confirmed by PCR
analysis and the positive WNV reactions
might have been due to infections with cross-
reactive agents or caused by molecular mimic-
ry of host-derived antigens.11,12
During the 1999 outbreak of West Nile virus
infections in New York, mortality was observed
in humans, horses and one cat.13 In cats that
were experimentally infected through mosquito
bites, mild, non-specific signs including lethar-
gy and a modest decrease in appetite were
observed during the first week after challenge.
No neurological signs occurred.7 Infection could
also be established after oral exposure through
ingestion of infected mice. The magnitude and
duration of viraemia was similar to that in cats
infected by mosquito bites. However, clinical
signs were not observed. The level of viraemia
in cats was higher than that in dogs included in
the same study. The duration of viraemia
ranged from 3.5–4.5 days. The level of viraemia
observed in cats might be high enough to infect
mosquitos at low efficiency. However, cats are
not considered to be epidemiologically impor-
tant amplifying hosts.7
Diagnosis
Since feline WNV infection is mostly subclini-
cal, the need for specific diagnostic tests for
cats is limited. In humans and horses, a diag-
nosis of WNV infection can be established
through detection of the virus or virus-specific
antibodies. Acute infection can be confirmed
by detecting virus-specific immunoglobulin M
antibodies, although antibodies may be absent
in the early phase of infection. A significant
rise in WNV antibodies in paired acute and
convalescent sera can be determined as evi-
dence of acute infection. A test for neutralising
antibodies can also be performed, but this
requires special facilities and will not be
offered by most laboratories. other serological
assays are performed, such as an epitope-
blocking ELISA.14 If they are to be used in the
diagnosis of infection in cats these assays need
to be standardised for use with feline sera.
Virus can be detected by reverse transcrip-
tion PCR in blood samples or infected tissues
at necropsy. However, viraemia is short-lived
and PCR might be negative in a patient at the
time of clinical presentation. Virus can also be
detected in tissues by in situ hybridisation
and immunohistochemistry. 
Treatment and prevention
There is no specific treatment for WNV infec-
tion. In a cat with clinical signs suspected to
be due to WNV infection, symptomatic treat-
ment is indicated.
Several vaccines are available for protection
against WNV infection in horses. The efficacy
of a recombinant canarypox-vectored WNV
vaccine was also studied in dogs and cats.15
As expected, clinical signs did not develop in
any of the cats (control and vaccinated 
animals) after challenge. However, the vacci-
nated cats were shown to develop virus-
neutralising antibodies and were protected
against viraemia after challenge. This demon-
strates the potential of the vaccine for protec-
tion against infection in cats [EBM grade II]. 
A commercial vaccine for cats is not available.
Since current WNV strains cause no or only
minimal and occasional clinical signs, a feline
vaccine is currently not required. 
Mosquito control can reduce the risk of
infection. Similar control measures as imple-
mented for prevention of mosquito bites in
humans and horses might be taken. 
Although seroprevalence of WNV infection 
in endemic areas can be high, clinical disease 
and mortality are rarely reported in cats.
REV IEW / ABCD guidelines on West Nile virus infection
EBM grades
The ranking system
for grading the level




of this article is
described on 
page 574 of this
Special Issue.
617_619_West Nile virus.qxp_FAB  27/05/2015  15:49  Page 618
 at Universite de Liege on November 8, 2015jfm.sagepub.comDownloaded from 
JFMS CLINICAL PRACTICE 619
REV IEW / ABCD guidelines on West Nile virus infection 
Funding
The authors received no specific grant from any
funding agency in the public, commercial or not-for-
profit sectors for the preparation of this article. The
ABCD is supported by Merial, but is a scientifically
independent body and its members receive no
stipends from Merial.
Conflict of interest
The authors do not have any potential conflicts of
interest to declare.
References 
1   Petersen LR, Brault AC and Nasci RS. West Nile
virus: review of the literature. JAMA 2013; 310:
308–315. 
2   Sambri V, Capobianchi M, Charrel R, et al. West
Nile virus in Europe: emergence, epidemiolo-
gy, diagnosis, treatment, and prevention.
Clin Microbiol Infect 2013; 19: 699–704. 
3   Petersen LR and Hayes EB. West Nile virus in
the Americas. Med Clin North Am 2008; 92:
1307–1322.
4   Komar N, Langevin S, Hinten S, et al.
Experimental infection of North American
birds with the New York 1999 strain of West
Nile virus. Emerg Infect Dis 2003; 9: 311–322.
5   Lim SM, Koraka P, osterhaus ADME, et al. 
West Nile virus: immunity and pathogenesis.
Viruses 2011; 3: 811–828.
6   Martin-Acebes MA and Saiz JC. West Nile virus:
a re-emerging pathogen revisited. World J Virol
2012; 1: 51–70. 
7   Austgen LE, Bowen RA, Bunning ML, et al.
Experimental infection of cats and dogs with
West Nile virus. Emerg Infect Dis 2004; 10: 
82–86. 
8   Kile JC, Panella NA, Komar N, et al. Serologic
survey of cats and dogs during an epidemic of
West Nile virus infection in humans. J Am Vet
Med Assoc 2005; 226: 1349–1353. 
9   Lan D, Ji W, Yu D, et al. Serological evidence of
West Nile virus in dogs and cats in China. Arch
Virol 2011; 156: 893–895. 
10 Levy JK, Lappin MR, Glaser AL, et al.
Prevalence of infectious diseases in cats and
dogs rescued following Hurricane Katrina.
J Am Vet Med Assoc 2011; 238: 311–317. 
11  Schwab S, Herden C, Seeliger F, et al. Non-sup-
purative meningoencephalitis of unknown ori-
gin in cats and dogs: an immunohistochemical
study. J Comp Pathol 2007; 136: 96–110. 
12 Schaudien D, Schwab S, Linke S, et al. Lack of
detectable West Nile virus RNA in brains and
kidneys of dogs and cats with immunohisto-
logical precipitates using virus-specific anti-
bodies. Vet Microbiol 2008; 132: 171–176. 
13 Komar N. West Nile viral encephalitis. Rev Sci
Tech 2000; 12: 166–176. 
14 Blitvich BJ, Bowen RA, Marlenee NL, et al.
Epitope-blocking enzyme-linked immunosor-
bent assays for detection of West Nile virus
antibodies in domestic mammals. J Clin
Microbiol 2003; 41: 2676–2679. 
15 Karaca K, Bowen R, Austgen LE, et al.
Recombinant canarypox vectored West Nile
virus (WNV) vaccine protects dogs and cats
against a mosquito WNV challenge. Vaccine
2005; 23: 3808–3813. 
< West Nile virus (WNV) has a broad host range, infecting mainly birds and mosquitos, 
but also mammals (including humans), reptiles, amphibians and ticks.
< WNV is maintained in a bird–mosquito–bird transmission cycle.
< Infection in cats occurs through mosquito bites or ingestion of infected small mammals
and probably also birds.
< Clinical disease and mortality are rarely reported in cats.
< Experimentally infected cats show mild, non-specific signs including lethargy and 
loss of appetite.
< If a cat is suspected of clinical signs due to acute WNV infection, symptomatic treatment
is indicated.
< Since current WNV strains cause no or only minimal and occasional clinical 
signs, a feline vaccine is currently not required.
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